Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07021911
Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer
Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico
View on ClinicalTrials.gov
Summary
The primary objective of the study is to describe the tolerance profile of radiation treatments performed during systemic treatment with new drugs (molecular targeted therapies, immunotherapy, others).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2023-05-17
Completion Date
2029-05-17
Last Updated
2025-06-15
Healthy Volunteers
No
Conditions
Interventions
RADIATION
Radiotherapy
Conventional fractionated radiotherapy, moderate hypofractionated radiotherapy, stereotactic radiotherapy (SABR)
Locations (1)
Radiation Oncology Department Fondazione Policlinico Campus BioMedico
Rome, Italy, Italy